These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35280799)

  • 1. A Predictive Model of 2yDFS During MR-Guided RT Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.
    Chiloiro G; Boldrini L; Preziosi F; Cusumano D; Yadav P; Romano A; Placidi L; Lenkowicz J; Dinapoli N; Bassetti MF; Gambacorta MA; Valentini V
    Front Oncol; 2022; 12():831712. PubMed ID: 35280799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer.
    Chiloiro G; Cusumano D; Romano A; Boldrini L; Nicolì G; Votta C; Tran HE; Barbaro B; Carano D; Valentini V; Gambacorta MA
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics-enhanced early regression index for predicting treatment response in rectal cancer: a multi-institutional 0.35 T MRI-guided radiotherapy study.
    Boldrini L; Chiloiro G; Cusumano D; Yadav P; Yu G; Romano A; Piras A; Votta C; Placidi L; Broggi S; Catucci F; Lenkowicz J; Indovina L; Bassetti MF; Yang Y; Fiorino C; Valentini V; Gambacorta MA
    Radiol Med; 2024 Apr; 129(4):615-622. PubMed ID: 38512616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta radiomics for rectal cancer response prediction using low field magnetic resonance guided radiotherapy: an external validation.
    Cusumano D; Boldrini L; Yadav P; Yu G; Musurunu B; Chiloiro G; Piras A; Lenkowicz J; Placidi L; Romano A; De Luca V; Votta C; Barbaro B; Gambacorta MA; Bassetti MF; Yang Y; Indovina L; Valentini V
    Phys Med; 2021 Apr; 84():186-191. PubMed ID: 33901863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy.
    Cusumano D; Boldrini L; Yadav P; Casà C; Lee SL; Romano A; Piras A; Chiloiro G; Placidi L; Catucci F; Votta C; Mattiucci GC; Indovina L; Gambacorta MA; Bassetti M; Valentini V
    Diagnostics (Basel); 2021 Jan; 11(1):. PubMed ID: 33466307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach.
    Boldrini L; Cusumano D; Chiloiro G; Casà C; Masciocchi C; Lenkowicz J; Cellini F; Dinapoli N; Azario L; Teodoli S; Gambacorta MA; De Spirito M; Valentini V
    Radiol Med; 2019 Feb; 124(2):145-153. PubMed ID: 30374650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation and comparison of MR-based radiomics models for predicting pathological complete response in locally advanced rectal cancer: a two-centre, multi-vendor study.
    Wei Q; Chen Z; Tang Y; Chen W; Zhong L; Mao L; Hu S; Wu Y; Deng K; Yang W; Liu X
    Eur Radiol; 2023 Mar; 33(3):1906-1917. PubMed ID: 36355199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric MRI-based radiomic model for predicting lymph node metastasis after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Wei Q; Chen L; Hou X; Lin Y; Xie R; Yu X; Zhang H; Wen Z; Wu Y; Liu X; Chen W
    Insights Imaging; 2024 Jun; 15(1):163. PubMed ID: 38922456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-based pre-Radiomics and delta-Radiomics models accurately predict the post-treatment response of rectal adenocarcinoma to neoadjuvant chemoradiotherapy.
    Wang L; Wu X; Tian R; Ma H; Jiang Z; Zhao W; Cui G; Li M; Hu Q; Yu X; Xu W
    Front Oncol; 2023; 13():1133008. PubMed ID: 36925913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.
    Autorino R; Gui B; Panza G; Boldrini L; Cusumano D; Russo L; Nardangeli A; Persiani S; Campitelli M; Ferrandina G; Macchia G; Valentini V; Gambacorta MA; Manfredi R
    Radiol Med; 2022 May; 127(5):498-506. PubMed ID: 35325372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta Radiomics Can Predict Distant Metastasis in Locally Advanced Rectal Cancer: The Challenge to Personalize the Cure.
    Chiloiro G; Rodriguez-Carnero P; Lenkowicz J; Casà C; Masciocchi C; Boldrini L; Cusumano D; Dinapoli N; Meldolesi E; Carano D; Damiani A; Barbaro B; Manfredi R; Valentini V; Gambacorta MA
    Front Oncol; 2020; 10():595012. PubMed ID: 33344243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Wan L; Peng W; Zou S; Ye F; Geng Y; Ouyang H; Zhao X; Zhang H
    Acad Radiol; 2021 Nov; 28 Suppl 1():S95-S104. PubMed ID: 33189550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractal-Based Radiomic Approach to Tailor the Chemotherapy Treatment in Rectal Cancer: A Generating Hypothesis Study.
    Di Dio C; Chiloiro G; Cusumano D; Catucci F; Boldrini L; Romano A; Meldolesi E; Marazzi F; Corvari B; Barbaro B; Manfredi R; Valentini V; Gambacorta MA
    Front Oncol; 2021; 11():774413. PubMed ID: 34956893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
    Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multiple-time-scale comparative study for the added value of magnetic resonance imaging-based radiomics in predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Peng W; Wan L; Wang S; Zou S; Zhao X; Zhang H
    Front Oncol; 2023; 13():1234619. PubMed ID: 37664046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Yi X; Pei Q; Zhang Y; Zhu H; Wang Z; Chen C; Li Q; Long X; Tan F; Zhou Z; Liu W; Li C; Zhou Y; Song X; Li Y; Liao W; Li X; Sun L; Pei H; Zee C; Chen BT
    Front Oncol; 2019; 9():552. PubMed ID: 31293979
    [No Abstract]   [Full Text] [Related]  

  • 17. Feasibility of delta radiomics-based pCR prediction for rectal cancer patients treated with magnetic resonance-guided adaptive radiotherapy.
    Wu J; Xiao J; Li Y; Wu F; Peng Q; Li C; Tang B; Orlandini LC
    Front Oncol; 2023; 13():1230519. PubMed ID: 38074653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study.
    Xiang Y; Li S; Wang H; Song M; Hu K; Wang F; Wang Z; Niu Z; Liu J; Cai Y; Li Y; Zhu X; Geng J; Zhang Y; Teng H; Wang W
    Clin Transl Radiat Oncol; 2023 Jan; 38():175-182. PubMed ID: 36471751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer.
    Li Y; Liu W; Pei Q; Zhao L; Güngör C; Zhu H; Song X; Li C; Zhou Z; Xu Y; Wang D; Tan F; Yang P; Pei H
    Cancer Med; 2019 Dec; 8(17):7244-7252. PubMed ID: 31642204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-parametric MRI radiomics for predicting response to neoadjuvant therapy in patients with locally advanced rectal cancer.
    Zhu W; Xu Y; Zhu H; Qiu B; Zhan M; Wang H
    Jpn J Radiol; 2024 Dec; 42(12):1448-1457. PubMed ID: 39073521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.